{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:08:02Z","timestamp":1777421282503,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"\u201cAssessorato alla Sanit\u00e0 Regione Piemonte,\u201d"},{"DOI":"10.13039\/100007364","name":"\u201cFondazione CRT,\u201d","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007364","id-type":"DOI","asserted-by":"crossref"}]},{"name":"\u201cCompagnia di San Paolo di Torino.\u201d"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.clbc.2013.08.012","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T09:49:29Z","timestamp":1385027369000},"page":"433-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Metformin Decreases Circulating Androgen and Estrogen Levels in Nondiabetic Women With Breast Cancer"],"prefix":"10.1016","volume":"13","author":[{"given":"Carlo","family":"Campagnoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Venturelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Abb\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Biglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Cogliati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saverio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianna","family":"Zito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Pasanisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2013.08.012_bib1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10549-012-2170-x","article-title":"Metformin and breast cancer risk: a meta-analysis and critical literature review","volume":"135","author":"Col","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2013.08.012_bib2","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1200\/JCO.2011.39.7505","article-title":"Diabetes, metformin, and breast cancer in postmenopausal women","volume":"30","author":"Chlebowski","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.012_bib3","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/cncr.26439","article-title":"Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer","volume":"118","author":"Bayraktar","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2013.08.012_bib4","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","article-title":"Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer","volume":"27","author":"Jiralerspong","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.012_bib5","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/annonc\/mdr534","article-title":"Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer","volume":"23","author":"He","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2013.08.012_bib6","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JME-12-0007","article-title":"Metformin in cancer: translational challenges","volume":"48","author":"Dowling","year":"2012","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.clbc.2013.08.012_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00280-012-1977-9","article-title":"Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer","volume":"71","author":"Esteva","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clbc.2013.08.012_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10549-010-1224-1","article-title":"Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents","volume":"126","author":"Goodwin","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2013.08.012_bib9","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1940-6207.CAPR-10-0175","article-title":"Metformin and other biguanides in oncology: advancing the research agenda","volume":"3","author":"Pollak","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.clbc.2013.08.012_bib10","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1530\/ERC-11-0374","article-title":"Obesity, type 2 diabetes, and cancer: the insulin and IGF connection","volume":"19","author":"Cohen","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.clbc.2013.08.012_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.2009.26.4473","article-title":"Associations of insulin resistance and adiponectin with mortality in women with breast cancer","volume":"29","author":"Duggan","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.012_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1200\/JCO.2002.20.1.42","article-title":"Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study","volume":"20","author":"Goodwin","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.012_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jnci\/djn415","article-title":"Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women","volume":"101","author":"Gunter","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2013.08.012_bib14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.26071","article-title":"Prospective study on the role of glucose metabolism in breast cancer occurrence","volume":"130","author":"Sieri","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2013.08.012_bib15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clbc.2013.08.012_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ijc.20582","article-title":"Serum testosterone levels and breast cancer recurrence","volume":"113","author":"Berrino","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2013.08.012_bib17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/1055-9965.EPI-10-1240","article-title":"Sex hormone concentrations and the risk of breast cancer recurrence in postmenopausal women without hot flashes","volume":"20","author":"Emond","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2013.08.012_bib18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/jnci\/djr031","article-title":"Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers","volume":"103","author":"Farhat","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2013.08.012_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jsbmb.2007.05.012","article-title":"Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk","volume":"106","author":"Hankinson","year":"2007","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clbc.2013.08.012_bib20","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1158\/1940-6207.CAPR-11-0090","article-title":"Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study","volume":"4","author":"James","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.clbc.2013.08.012_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bjc.2011.254","article-title":"Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies","volume":"105","author":"Key","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2013.08.012_bib22","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1200\/JCO.2006.09.0118","article-title":"Plasma testosterone and prognosis of postmenopausal breast cancer patients","volume":"25","author":"Micheli","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.012_bib23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1158\/1055-9965.EPI-07-0761","article-title":"Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer","volume":"17","author":"Rock","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2013.08.012_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clbc.2012.03.004","article-title":"Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study","volume":"12","author":"Campagnoli","year":"2012","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2013.08.012_bib25","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.fertnstert.2010.01.064","article-title":"Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial","volume":"94","author":"Patel","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clbc.2013.08.012_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ijc.24709","article-title":"The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women","volume":"126","author":"Danforth","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clbc.2013.08.012_bib27","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1210\/jc.2007-0581","article-title":"Ovarian androgen production in postmenopausal women","volume":"92","author":"Fogle","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clbc.2013.08.012_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e3181e195a6","article-title":"Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?","volume":"18","author":"Labrie","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.clbc.2013.08.012_bib29","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1152\/ajpendo.00039.2008","article-title":"Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis","volume":"296","author":"Blouin","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clbc.2013.08.012_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mce.2011.06.012","article-title":"Steroid sulfatase: a pivotal player in estrogen synthesis and metabolism","volume":"340","author":"Purohit","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.clbc.2013.08.012_bib31","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.steroids.2011.02.029","article-title":"Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women","volume":"76","author":"Key","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.clbc.2013.08.012_bib32","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.steroids.2011.02.040","article-title":"Recent data on intratumor estrogens in breast cancer","volume":"76","author":"Lonning","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.clbc.2013.08.012_bib33","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/bcr3040","article-title":"The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study","volume":"13","author":"Tworoger","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"suppl 2","key":"10.1016\/j.clbc.2013.08.012_bib34","first-page":"S29","article-title":"Nutritional advice to breast cancer survivors","volume":"18","author":"Pasanisi","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clbc.2013.08.012_bib35","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A\u00a0critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clbc.2013.08.012_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1677\/joe.1.06811","article-title":"Tissue-specific transcriptional initiation and activity of steroid sulfatase complementing dehydroepiandrosterone sulfate uptake and intracrine steroid activations in human adipose tissue","volume":"190","author":"Dalla Valle","year":"2006","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.clbc.2013.08.012_bib37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","article-title":"Metformin directly inhibits androgen production in human thecal cells","volume":"76","author":"Attia","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clbc.2013.08.012_bib38","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clbc.2013.08.012_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review","volume":"30","author":"Palomba","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.clbc.2013.08.012_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/meta.2002.29997","article-title":"Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women","volume":"51","author":"Maturana","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.clbc.2013.08.012_bib41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1196\/annals.1365.011","article-title":"Ovarian and adrenal hyperandrogenism","volume":"1092","author":"Carmina","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clbc.2013.08.012_bib42","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0015-0282(16)55220-0","article-title":"Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion","volume":"58","author":"Lanzone","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clbc.2013.08.012_bib43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2265.2008.03459.x","article-title":"The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis","volume":"70","author":"Barba","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clbc.2013.08.012_bib44","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1210\/jc.2012-1233","article-title":"Endogenous sex hormone changes in postmenopausal women in the diabetes prevention program","volume":"97","author":"Kim","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clbc.2013.08.012_bib45","first-page":"434","article-title":"Androgen receptor as a targeted therapy for breast cancer","volume":"2","author":"Garay","year":"2012","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.clbc.2013.08.012_bib46","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1210\/me.2012-1107","article-title":"Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?","volume":"26","author":"Hickey","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.clbc.2013.08.012_bib47","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/bcr2858","article-title":"Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer","volume":"13","author":"Naderi","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2013.08.012_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccr.2011.05.026","article-title":"Targeting androgen receptor in estrogen receptor-negative breast cancer","volume":"20","author":"Ni","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clbc.2013.08.012_bib49","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr2413","article-title":"Androgens and the breast","volume":"11","author":"Dimitrakakis","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2013.08.012_bib50","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1158\/0008-5472.CAN-05-3984","article-title":"Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole","volume":"66","author":"Macedo","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2013.08.012_bib51","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1210\/me.2011-1314","article-title":"Research resource: interplay between the\u00a0genomic and transcriptional networks of androgen receptor and estrogen receptor alpha in luminal breast cancer cells","volume":"26","author":"Need","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.clbc.2013.08.012_bib52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1677\/ERC-09-0257","article-title":"Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment","volume":"17","author":"Takagi","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.clbc.2013.08.012_bib53","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.mce.2012.06.016","article-title":"Endocrine-related cancers and the role of AMPK","volume":"366","author":"Brown","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.clbc.2013.08.012_bib54","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1210\/en.2009-0540","article-title":"Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway","volume":"150","author":"Rice","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.clbc.2013.08.012_bib55","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1200\/JCO.2009.23.9616","article-title":"Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women","volume":"28","author":"Dunbier","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.08.012_bib56","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/j.1349-7006.2011.02018.x","article-title":"Sex steroid hormones in pairs of tumor and\u00a0serum from breast cancer patients and pathobiological role of androstene-3\u03b2, 17\u03b2-diol","volume":"102","author":"Honma","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clbc.2013.08.012_bib57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10549-010-0761-y","article-title":"Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers","volume":"124","author":"Castellano","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2013.08.012_bib58","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/annonc\/mdq678","article-title":"Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers","volume":"22","author":"Park","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2013.08.012_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-013-2505-2","article-title":"Postmenopausal breast cancer, androgens, and aromatase inhibitors","volume":"139","author":"Campagnoli","year":"2013","journal-title":"Breast Cancer Res Treat"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820913001869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820913001869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:00Z","timestamp":1761513180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820913001869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1526820913001869"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2013.08.012","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin Decreases Circulating Androgen and Estrogen Levels in Nondiabetic Women With Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2013.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}